Urinary Tract Infection Treatment Market

Urinary Tract Infection Treatment Market size is
projected to experience significant growth from
2017 to 2024: Global Market Insights Inc.
Urinary Tract Infection (UTI) Treatment Market size should witness significant growth
due to increasing prevalence of urinary tract infections. The females are much more
susceptible to this disease compared to the males. Increased sexual activity, use of
certain birth control measures such as diaphragm and menopause further increases the
risk. Increasing antimicrobial resistance and high recurrence rates pertaining will serve
to be high impact rendering factor.
Diabetes and obesity are among the major risk factor and prevalence of these disease is
rising across the globe. Increased blood glucose level and defective immune system in
diabetes mellitus considerably increases the chances of infection. Pregnancy, long term
use of catheters, immune suppression and urologic abnormalities are some other risk
factor than may increase the incidences of the urinary tract disease. Growing obesity
rates should further drive the urinary tract infection treatment market across over
forecast timeframe.
Emerging technologies for the accurate and timely diagnosis should increase the
number of diagnosed cases and will help to treat patients more effectively. Emerging
technologies such as microfluidics and biosensors will improve diagnosis of disease
enhancing patient care. Such technological advancements will boost the urinary tract
infection treatment market over the forecast period. Excessive cost associated with the
R&D coupled with increasing awareness leading to the prevention of infection should
limit the urinary tract infection treatment market growth to some extent.
Fluoroquinolones drug segment is expected to show robust growth over forecast period
as it is most commonly prescribed by the physicians. Ciprofloxacin, levofloxacin, and
enoxacin are among the most widely used drugs for treatment. Optimal
pharmacokinetics, availability in oral dosage form and effectiveness against multidrugresistant
organism is expected to boost the fluoroquinolone dug segment growth.
Complicated urinary tract infection occurs in individual with functional and structural
abnormalities in the genitourinary tract is highly prevalent in renal failure. The
increasing microbial resistance rendering this type is difficult to treat. Failure of current
medicines to treat resistant microbes will fuel the demand for better treatment options.
1 | P a g e

Browse key industry insights from the report “Urinary Tract Infection Treatment
Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany,
UK, Italy, France, Spain, Italy, Russia, Poland, China, India, Japan, Australia, Brazil,
Mexico, Argentina, South Africa, Saudi Arabia, Qatar, UAE), Application
Development Potential, Price Trends, Competitive Market Share & Forecast, 2017
– 2024” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/urinary-tract-infection-treatmentmarket
Online pharmacy segment will grow over the forecast period due to increasing number
of online pharmacies. The lower cost of drugs and convenience associated with the
online pharmacies should further propel the segment growth. However, the substantial
number of illegitimate online pharmacies selling fake products and stringent regulation
governing the online pharmacies will restrict the segment growth to some extent.
U.S will witness significant growth over the forecast period due to presence of large
patient pool. According to Centers for Disease Control and Prevention around 8 million
people suffered from urinary tract infection every year and around 80% of women in
U.S. are diagnosed with infection at least once in lifetime. Asia pacific is expected to
show rapid growth over forecast period owing to the rapidly aging population, high
prevalence of chronic diseases like diabetes and renal failure. The lack of awareness in
the region will restrain the urinary tract infection treatment market growth to some
extent.
Some of the industry players are Roche, Pfizer, Cipla, Johnson & Johnson, Bayer,
GlaxoSmithKline, Emcure pharmaceuticals, Biosense Webster, St. Jude Medical,
Cardiofocus, Articure, Biotronik, and Cardima. Actavis, Zerbaxa, Forest Laboratories and
Depomed. The industry players focus innovative product launch to expand their
business portfolio as main strategies. For instance, Roche diagnostics launched
automated testing analyzer for the accurate diagnosis of the urinary tract infections.
Companies operating in this market have been also trying to gain approvals for various
dosage forms to fasten the treatment duration. Like, Zydus Pharma on June 1, 2017 got
approval for Levofloxacin injectable.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market data
specially designed and presented to aid strategic decision making.
2 | P a g e

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com/
3 | P a g e